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Abstract
To assess the burden of neurocysticercosis (NCC) in California we examined statewide hospital discharge data for 2009.
There were 304 cases hospitalized with NCC identified (incidence=0.8 per 100,000). Cases were mostly Latino (84.9%),
slightly more likely to be male than female (men 57.6%, women 42.4%) with an average age of 43.5 years. A majority of
cases were hospitalized in Southern California (72.1%) and many were hospitalized in Los Angeles County (44.7%). Men
were more likely than women to have severe disease including hydrocephalus (29.7% vs. 18.6%, p=0.027), resulting in
longer hospitalizations (.4 days, 48.0% vs. 32.6%, p=0.007) that were more costly (charge.$40 thousand men=46.9% vs.
woman=4.1%, p=0.026). Six deaths were recorded (2.0%). The total of NCC-related hospital charges exceeded $17 million;
estimated hospital costs exceeded $5 million. Neurocysticercosis causes appreciable disease and exacts a considerable
economic burden in California.
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Introduction
Neurocysticercosis (NCC) is associated with severe disease
morbidity and mortality across the globe, including the United
States where its impact has been studied primarily in the states of
California [1,2,3,4], Texas [5] and Oregon [6]. Though NCC
mortality is rare in the United States (3.9 per million population),
nearly 60% of U.S. deaths occurs in California (126/221 deaths
over 12 year study period) [7]. This parasitic disease is
preventable, causing premature death globally and has been
identified by the WHO as a potentially eradicable disease. Taenia
solium eggs in the feces of a tapeworm carrier (taeniasis) are the
source of the infection. By identifying and treating taeniasis
tapeworm carriers, the risk for exposure can be eliminated.
Taeniasis infection is acquired through the consumption of
undercooked pork containing the larval form of Taenia cysts.
NCC is not reportable in most jurisdictions and data on the
burden of this parasitic disease in the United States are lacking.
Moreover, few population-based data sources are available. A
recent published article on neglected infections of poverty has
drawn attention to the need for additional data for NCC [8]. In
addition, the economic impact of NCC can be sizable, with the
average charge of a NCC hospitalization in Los Angeles County
($66 thousand) [1] considerably more costly than the average
hospital charge in the U.S. in 2008 ($29 thousand) [9].
The clinical presentation of NCC generally takes on two forms
depending on the location of the cerebral lesions [10]. Lesions
appearing in the parenchymal area of the brain are characterized
by seizures and associated with cerebral edema. Occasionally,
these cases may develop intracranial hypertension which can be
lethal without interventions such as a decompression craniotomy
to allow the brain to swell. However, parenchymal NCC is
generally a more benign form of NCC. In comparison, lesions
forming in the extraparenchymal area of the brain often lead to a
more serious form of the disease due to the obstruction and
accumulation of cerebrospinal fluid in the ventricles, or cavities, of
the brain causing hydrocephalus. This condition may also lead to
intracranial hypertension and can be lethal without intervention
such as a shunting procedure to remove excess fluid.
Several studies have pointed out that some individuals identified
with NCC lesions have minimal inflammatory response to these
lesions and little or no symptoms of infection, indicating that the
degree of immune response and severity of illness may vary
considerably by individual. An earlier study of parenchymal NCC
in Mexico indicated that women with this infection present more
frequently with severe illness than men [11]. Another study in
Mexico also identified that females with parenchymal NCC present
with more evidence of focal edema around cysticerci in CT scans as
compared to men with the same infection, suggesting more severe
illness among females and potentially some difference in immune
response by gender to this organism [12]. In addition, this same
studyfoundlittle differenceintheimmuneresponsebygenderwhen
reviewing extraparenchymal NCC cases, suggesting similar levels of
illness severity by gender for extraparenchymal NCC.
We examined the distribution and burden of NCC in California
using hospital discharge data and explored the incidence of NCC
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leading to lengthy and costly hospitalizations. We also reviewed
the demographics of those presenting with diagnosis suggestive of a
parenchymal NCC infection as well as extraparenchymal NCC
infection. Common procedures performed on NCC hospitaliza-
tions were also reviewed and the total NCC-related hospitalization
charges were computed. In addition, we also describe new
methodology to identify individual cases from a de-identified
hospital discharge dataset that potentially contains multiple visits
of the same case.
Methods
We defined a NCC case hospitalized in California as a resident
having a hospital discharge diagnosis of cysticercosis (ICD9 123.1)
as a primary or additional diagnosis (1–24) AND also diagnosed
with one of the following 1) hydrocephalus, seizures (including
epileptic convulsions), cerebral edema or cerebral cyst. We used
the 2009 California Office of Statewide Health Planning and
Development (OSHPD) annual hospitalization discharge dataset
for this analysis. The dataset included demographic information,
primary diagnosis, up to 24 additional diagnoses and as many as
20 procedures performed while hospitalized. Also included in this
dataset are length of each hospitalization and resulting hospital-
ization charge. This is a public use dataset and identifiers such as
names have been removed.
We initially extracted data on all hospitalizations with a
discharge diagnosis of cysticercosis as a primary or additional
diagnosis (1–20) (ICD9=123.1, N=805) from the 2009 OSHPD
data set. Because this dataset contained multiple records in
instances where the same case was hospitalized more than once, a
sub-set was created containing one record for each case
hospitalized for cysticercosis. When possible, this is done by
reviewing the record linkage number (RLN; based on a coded
social security number) for each visit and eliminating duplicates.
Unfortunately, many of the RLN numbers for the cysticercosis
hospitalization dataset created were missing (31.6%, n=254). This
may be due to the fact that cysticercosis primarily impacts an
immigrant population in which many cases may not have social
security numbers. To overcome this problem, an algorithm was
created to assign a linkage number (RLN2) to hospital visits
lacking an RLN number. This new number was constructed from
demographic information available in the dataset such as age
(+/21 year), race, gender and home zip code.
This algorithm was tested against cysticercosis hospitalizations
having an actual RLN number (n=551) to assess its ability to
capture duplicate records from the same case. The algorithm was
successful in correctly assigning a hospitalization as either a single
visit or an additional visit for 94.9% of hospitalizations; 94.7% of
single hospitalizations were identified correctly and 95.3% of
duplicate hospitalizations were identified correctly. We then
assigned this newly constructed linkage number (RLN2) to
hospitalizations previously missing a linkage number, which
allowed us to create a dataset with one record for each case
hospitalized, even in instances where multiple hospitalizations had
been recorded (N=670). Finally, we applied the NCC case
definition described earlier to screen out any possible miscoding or
incidental findings. The resulting dataset containing 304 individual
NCC cases hospitalized in 2009 in CA was used for the study
analysis.
The diagnostic and procedural information from cases with
multiple visits was consolidated into one entry to facilitate analysis
of these variables at the individual level. Incidence rates were
calculated using population estimates from the California
Department of Finance. SAS version 9.1 software was used for
the analysis. Demographic differences in clinical illness and
lengthy and costly hospitalizations were analyzed using a
nonparametric chi-square testing. A lengthy hospitalization was
defined as having hospitalization for more than 4 days and a costly
hospital stay was defined as having a hospital charge greater than
$40,000. We also analyzed the demographics of those presenting
with diagnosis suggestive of a parenchymal NCC infection
(seizures) as well as extraparenchymal NCC infection (hydroceph-
alus) using non-parametric chi-square testing. The demographics
used in these analyses included gender (male, female), ethnicity
(Latino, non-Latino), age (0–19, 20–39, 40–59, 60 or more years)
and language spoken (Spanish, non-Spanish). Common proce-
dures performed on NCC cases were also reviewed as well as
computation of the total NCC-related hospitalization charges.
Results
In 2009, there were 805 hospitalizations in California listing
cysticercosis as a discharge diagnosis. There were 670 individual
cysticercosis cases that made up these hospitalizations. Of these,
there were 304 hospitalized persons that met the NCC case
definition (0.8 per 100,000 persons). By comparison, 8 years earlier
(2001) there were 792 total cysticercosis hospitalizations, 632
individual cysticercosis cases hospitalized and 386 persons
hospitalized with NCC (incidence 1.1 per 100,000 persons).
Of the 304 NCC cases hospitalized in 2009, there were 113
cases (37.2%) discharged with a primary diagnosis of cysticercosis.
Cases hospitalized for NCC were primarily Latino (84.9%) and
those who primarily speak Spanish (56.9%) (Table 1). The
prevalence of Spanish language preference was similar by gender
(men=58.3%, women=55.0%) and by age (greater than 40 years
50.9% vs. 49.1%). Those that were age 20 to 39 years had the
highest incidence of hospitalization of the age groups reviewed (1.3
per 100,000). There were 13 cases 19 years of age or younger; nine
were Hispanic (69.2%) and 7 were male (53.9%). Among all NCC
cases, the rate of hospitalization was slightly higher for men as
compared to women (0.9 and 0.7 per 100,000 respectively). The
Author Summary
Neurocysticercosis (NCC) is considered one of the major
neglected infections of poverty in the United States, with
mortality studies indicating that California bears the
highest burden of this disease. Although NCC is a
reportable disease in California, studies indicate that this
disease goes largely under-reported, contributing to the
lack of information about the disease distribution and
burden. In this manuscript, we reviewed the distribution of
NCC hospitalizations in California, demographics of those
hospitalized and total hospital-related charges for 2009.
This study revealed that a majority of persons hospitalized
with NCC in California receive their medical service in
Southern California hospitals, primarily in the County of
Los Angeles. As compared to women hospitalized for this
disease, men had a longer and more costly hospitalization
with more severe symptoms such as hydrocephalus, a
diagnosis suggestive of extraparenchymal infection. The
reasons for this difference in NCC severity by gender are
not clear, but do not appear to be due to delay in seeking
medical care or a language barrier. The intensity of
hospital care needed to manage these cases and the
sizable NCC hospitalization charge underscores the con-
siderable economic burden this disease presents in
California.
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(men=42.6 years, women=44.7 years). In comparison, the
average age of a NCC case hospitalized in 2001 was 38.0 years.
Many of the NCC cases hospitalized in 2009 had multiple
hospitalizations within the year reviewed (20.1%).
The majority of NCC cases in California were hospitalized in
the Southern California region (72.4%, 0.9 per 100,000) which
included the counties of Los Angeles (44.7%, 1.3 per 100,000),
Orange (8.5%, 0.8 per 100,000) and San Diego (7.9%, 0.8 per
100,000). Many of the NCC cases hospitalized in Northern
California occurred in the counties of Santa Clara (4.6%, 0.8 per
100,000) and Alameda (2.6%, 0.5 per 100,000).
Additional diagnoses identified among NCC cases included
seizures (74.3%), hydrocephalus (25.0%), cerebral cyst (7.6%) or
cerebral edema (6.6%). Some cases were diagnosed with both
hydrocephalus and seizures (7.5%). Many patients received a
neurological procedure while hospitalized (41.0%) which included
cranial procedures (25.0%) such as a ventricular shunt procedure
(14.8%) or the excision [or destruction of] a brain lesion (8.2%).
Some of these shunt procedures involved the removal and
replacement of a ventricular shunt (6.3%). The average length of
a hospital stay was 6.5 days and the average hospital charge was
$57.8 thousand dollars. Six deaths occurred during the period of
hospitalization (2.0%). Deaths occurred among both men (n=3)
and women (n=3) and all were Latino. Ages of deaths ranged
from 33–71 years (median 50.5 years). One death had hydro-
cephalus and had received a shunt procedure. One death had
cerebral edema and 4 others had diagnosis of seizure. Other health
conditions frequently listed among NCC cases include diabetes
(15.5%) and heart disease (12.8%). One case was also diagnosed
with taeniasis.
Overall, 41.5% of NCC cases had lengthy hospital stays (.4
days). Men were more likely to have a lengthy stay as compared to
women (men=48.0% vs. woman=32.6, p=0.007, Figure 1),
but age and race ethnicity were not associated with lengthy stays,
nor was language spoken. NCC cases with hydrocephalus were
more likely to have a lengthy stay as compared to cases without
hydrocephalus (63.2% vs. 34.2%, p,0.001), but cases with
seizures were not associated with a lengthy stay (37.2% vs.
53.9%), nor were those with cerebral edema (35.0% vs. 41.9%).
Chronic health conditions such as heart disease were associated
with a lengthy hospital stay (59.0% vs. 38.9%, p=0.017). Of
interest, heart disease was no more likely to be diagnosed among
men than women with NCC (men=10.9%, women=15.5%).
Other chronic health conditions such as diabetes were not
associated with a lengthy hospital stay (46.8% vs. 40.5%). Multiple
hospitalizations, another measure of health care utilization, was
not associated with gender (men=22.3%, woman=17.2%,
Figure 1) or age, race ethnicity or language spoken.
The percent of NCC cases having a costly hospitalization
(charges .$40,000) was 41.4%. By gender, men were also more
likely than woman to have had a costly hospitalization (46.9% vs.
34.1%, p=0.026, Figure 1), but other demographics such as age,
ethnicity and language spoken were not associated with a costly
hospitalization. NCC cases with hydrocephalus were associated
with a costly hospitalization as compared to those without
hydrocephalus (68.4% vs. 32.5%, p ,0.001), however cases with
seizures were not associated with a costly hospitalization (32.3%
vs. 68.0%), nor were those with cerebral edema (40.1 vs. 60.0%).
NCC cases with heart disease were also associated with a costly
hospitalization (59.0% vs. 38.9%, p=0.002), however those with
diabetes were not associated with a costly hospitalization (46.8%
vs. 40.5%).
NCC cases with hydrocephalus were associated with male
gender (men=29.7%, women=18.6%, p=0.027, Figure 1) and
associated with having an age greater than 20 years [no cases
under the age of 20 years identified]. Aside from this finding,
hydrocephalus was not associated with ethnicity, language spoken
or other age groups. Among those diagnosed with hydrocephalus
(n=76), men were more likely to be associated with a lengthy
hospitalization (.4 days) than women (men=71.2% vs. wom-
en=45.8%, p=0.03). However, there was no association with
costly hospitalizations (.$40,000) among NCC cases with
hydrocephalus by gender (men=71.2%, women=62.5%). Age,
race ethnicity and language spoken were not associated with
lengthy stays among NCC cases with hydrocephalus.
NCC cases with seizures were not associated by gender, age,
ethnicity or language spoken. By gender specifically, seizures
Table 1. Demographics of Persons Hospitalized with
Neurocysticercosis in California, 2009.
Hospitalizations n Percent
Incidence
(per 100,000)
All 304 100% 0.8
Race/Ethnicity
Latino 258 84.9% 1.8
Caucasian 26 8.6% 0.2
African American 3 1.0% 0.1
Other or unknown 17 5.6% -
Gender
Male 175 57.6% 0.9
Female 129 42.4% 0.7
Age Group
0–19 13 4.3% 0.3
20–39 134 44.1% 1.3
40–59 104 34.2% 1.0
60+ 53 17.4% 0.8
Primary Language Spoken
Spanish 173 56.9% -
English 131 43.1% -
Mean 95% CI
Mean Age (years) 43.5 41.6–45.4
Male 42.6 40.2–45.0
Female 44.7 41.7–47.8
Median Age (years) 41.0
Hospitalization Region* n Percent
Incidence
(per 100,000)
Southern California 220 72.4% 0.9
Los Angeles County 136 44.7% 1.3
Orange County 26 8.6% 0.8
San Diego 24 7.9% 0.8
San Bernardino 13 4.3% 0.6
Kern 12 3.9% 1.5
Northern California 84 27.6% 0.6
Santa Clara 14 4.6% 0.8
Alameda 8 2.6% 0.5
*Northern CA; 48 northern most counties. Southern CA; 10 southern most
counties.
Population data obtained from the CA Department of Finance.
doi:10.1371/journal.pntd.0001480.t001
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Figure 1). Among NCC cases with seizures (n=226), men
appeared to have a more lengthy hospital stay (44.2% vs. 27.8%,
p=0.011), but this finding was not significant when removing
NCC cases who also had hydrocephalus from the analysis
(n=209, 39.1% vs. 28.7%). Among NCC cases with seizures
(n=226), a costly hospitalization was not associated with gender
(men=36.4% vs. women=26.8%) or by age, race ethnicity or
language spoken. NCC cases with cerebral edema (n=20), also a
diagnosis suggestive of a parenchymal infection, was not associated
by gender (men=55.0% vs. women=45.0%, Figure 1) or age,
ethnicity or language spoken. NCC cases with cerebral edema
were not associated with more lengthy hospital stays (35.0% vs.
41.9%) or more costly hospital stays (60.0% vs. 40.1%).
Cranial procedures performed on hospitalized NCC cases was
not associated with gender (men=28.6% vs. women=20.2%,
Figure 1), age, ethnicity or language spoken. Shunting procedures
were not associated by gender (men=17.1% vs. women=11.6%)
age, ethnicity or language spoken. No shunting procedure was
performed on NCC cases less than 20 years of age. Shunting
procedures were almost exclusively performed on cases with
hydrocephalus (97.8%). A shunting procedure was associated with
having multiple hospitalizations (29.5% vs. 11.1%, p,0.001).
NCC cases having a brain lesion extraction were not associated by
gender (men=8.6%, women=7.8%) age, ethnicity or language
spoken. NCC cases requiring a brain lesion extraction (n=25)
involved cases with hydrocephalus (44.0%), seizures (52.0%) and
cerebral edema (8.0%), conditions not mutually exclusive.
In summary, the demographic that appeared the most
consistently associated with illness severity in this analysis was
male gender. A summary of severity indicators such as diagnosis,
procedures and hospital utilization are shown in Figure 1.
Discussion
Our findings support the notion that NCC remains a significant
problem in California, especially in Los Angeles County (LAC),
and the burden of severe disease and economic costs are
considerable. The number of hospitalized cases reported here
(n=304) far exceeds the number reported to the California State
Health Department (n=32) for 2009 [13] and illustrates the
considerable under-reporting of NCC. The incidence of NCC
hospitalization in 2008 in California is comparable to that found in
2001, indicating that the burden of disease has not changed much
in the last 8 years in California. The largest majority of cases were
among Latinos from Southern California counties. However,
NCC hospitalizations were observed across racial ethnic groups
and in 29 California counties.
The proportion of hospitalized NCC cases that were identified
as Latino in this study (84.9%) was slightly lower than that
identified in another study of NCC mortality in California (92.7%)
[2]. The average age of a NCC case hospitalized in California for
2009 (43.5 years) was older than that seen among hospitalized
NCC cases in 2001 (38.0 years) and also much older than that
found in earlier studies of hospitalized cases in LAC. One study of
hospitalized NCC cases in four hospitals in LAC (1973–83)
identified an average age of 31.1 years [3]. A study of cysticercosis
deaths in California (1989–2000) identified a mean age of 34.5
years [2]. The number of repeat hospitalizations per year
identified in this study is also larger than that found in another
more detailed study of hospitalized NCC cases in a single Texas
hospital (20% vs. 14%) [5]. These findings underscore the chronic
and debilitating nature of this disease. The results of our study may
indicate a shift in the demographics of the disease from a younger
age, more acute illness, to older age, more chronic illness. It may
Figure 1. Neurocysticercosis hospitalizations; additional diagnoses, procedures performed and hospital utilization by gender, CA
2009 (N=304). This figure shows that men hospitalized with neurocysticercosis have more severe symptoms requiring a longer and more costly
hospitalization than women with neurocysticercosis. Specifically, men hospitalized with neurocysticercosis were more likely to have an additional
diagnosis of hydrocephalus, to have a hospitalization exceeding four days and to have a hospital charge exceeding 40,000 dollars as compared to
women hospitalized with neurocysticercosis.
doi:10.1371/journal.pntd.0001480.g001
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cases are migrating from may be declining [14].
Our study found that the severity of NCC in California was
associated with male gender. Men were slightly more likely to be
hospitalized for NCC (58%). Other studies of reported cases have
also shown similar results; 54% male (LAC 1973–83) [3] and 58%
male (LAC 1981–88) [7]. Our study revealed that men with NCC
have longer and more costly hospitalizations as compared to
women hospitalized with the same infection. In addition, men
were found to have more severe disease that includes hydroceph-
alus, suggestive of a higher incidence of extraparenchymal
infection among men. These findings are consistent with the
finding of another study of NCC mortality in California indicates
that men have a mortality rate nearly twice that of women in CA
(5.2/10
6 vs. 2.7/10
6) [2]. This study also found that 31% of deaths
occur outside of a hospital setting and would not be captured in
our analysis. However, our findings differ from an earlier study
involving a Mexican study population suggesting that the
inflammatory response to extraparenchymal NCC infection does
not differs by gender, implying that severity of extraparenchymal
NCC should not differ by gender [12]. This earlier study also
suggests that the inflammatory response to parenchymal NCC is
more severe among women, where our study found little evidence
to support differences in severity of parenchymal infection by
gender. Some of these discrepancies may be the result of very
different study populations. The study group in Mexico [12] was
more likely comprised of NCC cases with locally acquired
infection whereas our study population is more likely to be
comprised of immigrants with exposure outside of the U.S. The
more urgent economic necessity for men to migrate to California
for employment may explain some of the difference in the study
findings.
This difference in NCC severity by gender does not appear to
be the result of gender differences in other chronic health
conditions such as heart disease or diabetes that could results in
more lengthy and costly hospitalizations. Could it be that men
delay seeking medical attention until their condition is more
severe? However, if this were true, we might expect the average
age of men hospitalized for NCC to be older than women, which
was not the case. Is it due to a language barrier in understanding
the management of this complicated disease? Is it that men receive
less care, or opt for less care once hospitalized? Our findings
suggest that this is also not the case. It may also be possible that the
difference in disease severity by gender identified in our study is
due to a difference in immune response to NCC as suggested in
this earlier study [12].
This is the first study that documents a method of managing a
de-identified public use hospital discharge dataset that is missing a
large number of RLN’s. This is especially important for analyzing
severe chronic diseases such as NCC where persons may have
multiple visits within the same year. As was identified in an earlier
study [1], the economic impact of NCC is sizeable. We found that
the total charges associated with NCC hospitalizations in
California exceeding $17.1 million annually. The average charge
for a NCC hospitalization in California for 2009 ($57.8 thousand)
was significantly higher than that of the average hospitalization
charge in the U.S. ($30.6 thousand) [9]. Based on the average
charge to cost to ratio for a hospitalization nationally in 2009
(3.0:1, n=39,434,956) [9], the estimated total cost of NCC
hospitalizations in California would be $5.1 million. The estimated
average cost of a NCC hospitalization in California in 2009 would
be $17.3 thousand. The average length of a NCC hospitalization
in 2009 (6.5 days) was also considerably longer than that of the
average hospitalization in the U.S. (4.6 days) [12]. The additional
costs, beyond hospitalization, of emergency room visits, outpatient
care, disability and days of work lost all contribute to the overall
financial impact of NCC.
Any conclusions based on hospital discharge data may be limited
for several reasons. It is possible that persons without an RLN (SSI)
number may be more likely to relocate and have a change in zip
code within a given year. This may cause multiple hospitalizations
by the same cases to be interpreted as separate persons hospitalized
when using the described method. Also, cases listed here as having
only one hospitalization may have other hospitalizations in the
previous year that would not be captured due to the selected study
period. In addition, hospitalizations of California residents outside
of California would not be captured by our data.
The hospital charges presented here may overestimate the
actual cost of hospitalization, as the actual amount received for
hospital services may be less than the amount charged. However,
we feel that the calculation of hospital charges can be useful when
used in comparison to an average hospital charge in the U.S. and
to hospital charges for other specific diseases.
It would be helpful to know how much transmission is occurring
in the US; however, this dataset does not have any information on
the case’s country of origin and how long cases have resided in the
US. Thus there is no way to know if any of these infections were
acquired locally verses their country of origin or through possible
exposure when traveling.
There is no information in the dataset regarding the type of
laboratory diagnostics used to make these diagnoses, making it
difficult to know how confident we can be in these diagnoses. It is
also possible that a patient may have been clinically diagnosed
with cysticercosis, but were not identified as such in the ICD9
discharge codes.
Finally, while we identified the number of incident hospitaliza-
tions for cysticercosis in this study, a distinction should be made
between incident hospitalizations and incident cases. This dataset
does not allow us to determine whether the hospitalization
represents a newly diagnosed case or a previously identified case.
In Conclusion, neurocysticercosis exacts a significant disease
and economic toll in California, especially in Los Angeles County.
Hospitalized NCC cases are primarily working age Latinos. As
compared to women, men are hospitalized with more severe
disease and more costly and longer hospital stays. The reason for
this difference in severity by gender is unclear, but potentially
gender should be considered by physicians for proper disease
management. NCC is a preventable disease and public health
efforts to identify and treat the tapeworm carrier could be
improved and adopted by other public health systems. Increased
reporting from hospitals and clinicians in California will allow for
public health follow-up of cases, identification and treatment of T.
solium tapeworm carriers, prevention of additional cases, and
reduction of the disease burden in California.
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